People around the country are now having their lives saved by a medicine made from the blood of people in Manchester ...

A patient from Telford who needed a lifesaving treatment developed from blood plasma has thanked donors. Over the past three ...

In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...

Kamada (NASDAQ:KMDA – Get Free Report) and Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based ...

NHS patients around the country are receiving a lifesaving medicine made from the plasma of blood donors in Shropshire.

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...

Argenx had cash, cash equivalents, and other short-term investments totaling $3.4 billion as of the end of 2024, making it well-positioned to continue funding its pipeline and commercialization ...

Fourth quarter 2024 total revenue of approximately $57.6 million, which includes TAVALISSE® net product sales of $31.0 million, REZLIDHIA® net product sales of $7.4 ...

As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...

The patient was transferred to this hospital to be evaluated for thrombotic thrombocytopenic purpura (TTP ... bone marrow failure may be directly immune-mediated, as in the case of aplastic ...